Salidroside Improved Bone Density in Animal Study

Researchers found that the compound helped restore bone mineral density in rats suffering from induced osteoporosis.

Updated on Sept. 26, 2026 in Nutrition

A close-up of a porous bone cross-section inside a glass petri dish on a laboratory table.
Researchers identified that salidroside modulates cellular pathways to restore bone mineral density in animal models treated with glucocorticoids, according to a recent study. AI Illustration. Upload story photo >

Live Poll

Would you rely on herbal supplements as a primary treatment for diagnosed medical conditions?

A new study has shown that salidroside can mitigate glucocorticoid-induced osteoporosis in animal models. The treatment successfully targeted cellular pathways to increase bone mineral density and reduce inflammation.

Why it matters

Understanding how natural compounds regulate the PI3K/Akt/mTOR signaling pathway offers new insights into potential treatments for bone-related diseases. This research provides a foundation for exploring alternative therapeutic options for conditions caused by glucocorticoid use.

The study measured a p < 0.001 statistical significance in bone mineral density improvements among test groups. Scientists also recorded binding affinities of -7.0 Kcal/mol for PI3K and -6.1 Kcal/mol for Akt proteins during molecular docking.

The players

Nature

Nature is a leading multidisciplinary science journal that publishes peer-reviewed research and primary investigative findings.

The details

Researchers treated 24 male rats with dexamethasone at 5 mg/kg to induce osteoporosis before administering oral salidroside at dosages of 50 and 100 mg/kg. The compound was found to modulate the PI3K/Akt/mTOR pathway, successfully lowering levels of inflammatory cytokines and oxidative stress markers.

Timeline

  1. 6 weeks was the duration used for osteoporosis induction via dexamethasone injections.

  2. 8 weeks was the duration for the oral administration of salidroside treatment.

The Big Picture

This finding follows a pattern set by the PI3K/Akt/mTOR signaling pathway research initiatives that explore cellular responses to inflammatory damage. The study highlights the expanding role of molecular docking to identify targeted interventions for metabolic and degenerative conditions.

This research is in the early preclinical stage and does not change current medical advice or treatment plans for human patients. Readers should consult their healthcare provider before adding new supplements to their daily routine to manage health conditions.

The takeaway

While these results in rats are promising, they represent only the initial phase of scientific investigation into salidroside. Further studies are required to determine if these benefits can be safely and effectively replicated in human subjects.

Further reading

Learn more about the latest developments in Nutrition research on our dedicated science page.

More information

Access the complete peer-reviewed research article to review the full methodology and findings.

Live Poll

Would you rely on herbal supplements as a primary treatment for diagnosed medical conditions?